Immunohematology Market By Product (Analyzers and Systems, Reagents) , By Application (Blood-related Diseases, HIV, Others) By End User (Hospitals, Diagnostic Laboratories, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global immunohematology market was valued at $1.9 billion in 2023, and is projected t%li%reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 t%li%2033.
Immunohematology, als%li%known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is t%li%ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient t%li%prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led t%li%a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing t%li%the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering t%li%the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfoli%li%for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented int%li%product, application, end user, and region. Depending on the product, the market is categorized int%li%analyzers & systems and reagents. By application, it is classified int%li%blood-related diseases, HIV, and others. According t%li%end user, the market is divided int%li%hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According t%li%end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Therm%li%Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising t%li%strengthen their position in the competitive environment.
Additional benefits you will get with this purchase are:
By Product
Immunohematology, als%li%known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is t%li%ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient t%li%prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led t%li%a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing t%li%the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering t%li%the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfoli%li%for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented int%li%product, application, end user, and region. Depending on the product, the market is categorized int%li%analyzers & systems and reagents. By application, it is classified int%li%blood-related diseases, HIV, and others. According t%li%end user, the market is divided int%li%hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According t%li%end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Therm%li%Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising t%li%strengthen their position in the competitive environment.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
By Product
- Analyzers and Systems
- Reagents
- Blood-related Diseases
- HIV
- Others
- Hospitals
- Diagnostic Laboratories
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Therm%li%Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Cardinal Health
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Reconstructive Joint Replacements
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Knee Replacement Implants
4.2.5.1. Market Size and Forecast
4.2.6. Hip Replacement Implants
4.2.6.1. Market Size and Forecast
4.2.7. Extremities
4.2.7.1. Market Size and Forecast
4.2.7.2. Upper Extremity Reconstruction
4.2.7.2.1. Market Size and Forecast
4.2.7.2.2. Shoulder
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Elbow
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Wrist
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2. Lower Extremity Reconstruction
4.2.7.2.1. Market Size and Forecast
4.2.7.2.2. Upper
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Lower
4.2.7.2.2.1. Market Size and Forecast
4.3. Spinal Implants
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Spinal fusion implants
4.3.5.1. Market Size and Forecast
4.3.5.2. Thoracolumbar devices
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Cervical fixation devices
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Interbody fusion devices
4.3.5.2.1. Market Size and Forecast
4.3.6. Invasive Spinal bone stimulators
4.3.6.1. Market Size and Forecast
4.3.7. Vertebral Compression Fracture (VCF) Devices
4.3.7.1. Market Size and Forecast
4.3.7.2. Balloon Kyphoplasty Devices
4.3.7.2.1. Market Size and Forecast
4.3.7.2. Vertebroplasty Devices
4.3.7.2.1. Market Size and Forecast
4.3.8. Motion Preservation Devices/Non-Fusion Devices
4.3.8.1. Market Size and Forecast
4.3.8.2. Dynamic Stabilization Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Artificial Disc Replacement Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Annulus Repair Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Nuclear Disc Prostheses
4.3.8.2.1. Market Size and Forecast
4.4. Dental Implants
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.4.5. Root Form Dental Implants
4.4.5.1. Market Size and Forecast
4.4.6. Plate Form Dental Implants
4.4.6.1. Market Size and Forecast
4.5. Trauma
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Orthobiologics
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.6.5. Demineralized Bone Matrix (DBM)
4.6.5.1. Market Size and Forecast
4.6.6. Allograft
4.6.6.1. Market Size and Forecast
4.6.7. Bone Morphogenetic Protein (BMP)
4.6.7.1. Market Size and Forecast
4.6.8. Viscosupplementation Products
4.6.8.1. Market Size and Forecast
4.6.9. Synthetic Bone Substitutes
4.6.9.1. Market Size and Forecast
4.6.10. Others
4.6.10.1. Market Size and Forecast
4.7. Others
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
CHAPTER 5: ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. Market Overview
5.1.1 Market Size and Forecast, By Biomaterial
5.2. Metallic Biomaterials
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.2.5. Stainless steel
5.2.5.1. Market Size and Forecast
5.2.6. Titanium Alloy
5.2.6.1. Market Size and Forecast
5.2.7. Cobalt Alloy
5.2.7.1. Market Size and Forecast
5.2.8. Others
5.2.8.1. Market Size and Forecast
5.3. Ceramic Biomaterials
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Polymeric Biomaterials
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: ORTHOPEDIC IMPLANTS MARKET, BY TYPE
6.1. Market Overview
6.1.1 Market Size and Forecast, By Type
6.2. Knee
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hip
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Wrist And Shoulder
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Dental
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Spine
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Ankle
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: ORTHOPEDIC IMPLANTS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Biomaterial
7.2.4. Market Size and Forecast, By Type
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Orthopedic Implants Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Biomaterial
7.2.6.3. Market Size and Forecast, By Type
7.2.7. Canada Orthopedic Implants Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Biomaterial
7.2.7.3. Market Size and Forecast, By Type
7.2.8. Mexico Orthopedic Implants Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Biomaterial
7.2.8.3. Market Size and Forecast, By Type
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Biomaterial
7.3.4. Market Size and Forecast, By Type
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Orthopedic Implants Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Biomaterial
7.3.6.3. Market Size and Forecast, By Type
7.3.7. France Orthopedic Implants Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Biomaterial
7.3.7.3. Market Size and Forecast, By Type
7.3.8. UK Orthopedic Implants Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Biomaterial
7.3.8.3. Market Size and Forecast, By Type
7.3.9. Italy Orthopedic Implants Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Biomaterial
7.3.9.3. Market Size and Forecast, By Type
7.3.10. Spain Orthopedic Implants Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Biomaterial
7.3.10.3. Market Size and Forecast, By Type
7.3.11. Rest of Europe Orthopedic Implants Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Biomaterial
7.3.11.3. Market Size and Forecast, By Type
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Biomaterial
7.4.4. Market Size and Forecast, By Type
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Orthopedic Implants Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Biomaterial
7.4.6.3. Market Size and Forecast, By Type
7.4.7. China Orthopedic Implants Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Biomaterial
7.4.7.3. Market Size and Forecast, By Type
7.4.8. India Orthopedic Implants Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Biomaterial
7.4.8.3. Market Size and Forecast, By Type
7.4.9. Australia Orthopedic Implants Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Biomaterial
7.4.9.3. Market Size and Forecast, By Type
7.4.10. South Korea Orthopedic Implants Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Biomaterial
7.4.10.3. Market Size and Forecast, By Type
7.4.11. Rest of Asia-Pacific Orthopedic Implants Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Biomaterial
7.4.11.3. Market Size and Forecast, By Type
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Biomaterial
7.5.4. Market Size and Forecast, By Type
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Orthopedic Implants Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Biomaterial
7.5.6.3. Market Size and Forecast, By Type
7.5.7. Saudi Arabia Orthopedic Implants Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Biomaterial
7.5.7.3. Market Size and Forecast, By Type
7.5.8. South Africa Orthopedic Implants Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Biomaterial
7.5.8.3. Market Size and Forecast, By Type
7.5.9. Rest of LAMEA Orthopedic Implants Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Biomaterial
7.5.9.3. Market Size and Forecast, By Type
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Globus Medical, Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Johnson And Johnson,
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Medtronic Plc
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Zimmer Biomet Holdings Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. NuVasive Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. CONMED Corporation
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Arthrex, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Smith And Nephew Plc
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Stryker Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Colfax Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Reconstructive Joint Replacements
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Knee Replacement Implants
4.2.5.1. Market Size and Forecast
4.2.6. Hip Replacement Implants
4.2.6.1. Market Size and Forecast
4.2.7. Extremities
4.2.7.1. Market Size and Forecast
4.2.7.2. Upper Extremity Reconstruction
4.2.7.2.1. Market Size and Forecast
4.2.7.2.2. Shoulder
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Elbow
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Wrist
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2. Lower Extremity Reconstruction
4.2.7.2.1. Market Size and Forecast
4.2.7.2.2. Upper
4.2.7.2.2.1. Market Size and Forecast
4.2.7.2.2. Lower
4.2.7.2.2.1. Market Size and Forecast
4.3. Spinal Implants
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Spinal fusion implants
4.3.5.1. Market Size and Forecast
4.3.5.2. Thoracolumbar devices
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Cervical fixation devices
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Interbody fusion devices
4.3.5.2.1. Market Size and Forecast
4.3.6. Invasive Spinal bone stimulators
4.3.6.1. Market Size and Forecast
4.3.7. Vertebral Compression Fracture (VCF) Devices
4.3.7.1. Market Size and Forecast
4.3.7.2. Balloon Kyphoplasty Devices
4.3.7.2.1. Market Size and Forecast
4.3.7.2. Vertebroplasty Devices
4.3.7.2.1. Market Size and Forecast
4.3.8. Motion Preservation Devices/Non-Fusion Devices
4.3.8.1. Market Size and Forecast
4.3.8.2. Dynamic Stabilization Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Artificial Disc Replacement Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Annulus Repair Devices
4.3.8.2.1. Market Size and Forecast
4.3.8.2. Nuclear Disc Prostheses
4.3.8.2.1. Market Size and Forecast
4.4. Dental Implants
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.4.5. Root Form Dental Implants
4.4.5.1. Market Size and Forecast
4.4.6. Plate Form Dental Implants
4.4.6.1. Market Size and Forecast
4.5. Trauma
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Orthobiologics
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.6.5. Demineralized Bone Matrix (DBM)
4.6.5.1. Market Size and Forecast
4.6.6. Allograft
4.6.6.1. Market Size and Forecast
4.6.7. Bone Morphogenetic Protein (BMP)
4.6.7.1. Market Size and Forecast
4.6.8. Viscosupplementation Products
4.6.8.1. Market Size and Forecast
4.6.9. Synthetic Bone Substitutes
4.6.9.1. Market Size and Forecast
4.6.10. Others
4.6.10.1. Market Size and Forecast
4.7. Others
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
CHAPTER 5: ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL
5.1. Market Overview
5.1.1 Market Size and Forecast, By Biomaterial
5.2. Metallic Biomaterials
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.2.5. Stainless steel
5.2.5.1. Market Size and Forecast
5.2.6. Titanium Alloy
5.2.6.1. Market Size and Forecast
5.2.7. Cobalt Alloy
5.2.7.1. Market Size and Forecast
5.2.8. Others
5.2.8.1. Market Size and Forecast
5.3. Ceramic Biomaterials
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Polymeric Biomaterials
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: ORTHOPEDIC IMPLANTS MARKET, BY TYPE
6.1. Market Overview
6.1.1 Market Size and Forecast, By Type
6.2. Knee
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hip
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Wrist And Shoulder
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Dental
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Spine
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Ankle
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: ORTHOPEDIC IMPLANTS MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product Type
7.2.3. Market Size and Forecast, By Biomaterial
7.2.4. Market Size and Forecast, By Type
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Orthopedic Implants Market
7.2.6.1. Market Size and Forecast, By Product Type
7.2.6.2. Market Size and Forecast, By Biomaterial
7.2.6.3. Market Size and Forecast, By Type
7.2.7. Canada Orthopedic Implants Market
7.2.7.1. Market Size and Forecast, By Product Type
7.2.7.2. Market Size and Forecast, By Biomaterial
7.2.7.3. Market Size and Forecast, By Type
7.2.8. Mexico Orthopedic Implants Market
7.2.8.1. Market Size and Forecast, By Product Type
7.2.8.2. Market Size and Forecast, By Biomaterial
7.2.8.3. Market Size and Forecast, By Type
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product Type
7.3.3. Market Size and Forecast, By Biomaterial
7.3.4. Market Size and Forecast, By Type
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Orthopedic Implants Market
7.3.6.1. Market Size and Forecast, By Product Type
7.3.6.2. Market Size and Forecast, By Biomaterial
7.3.6.3. Market Size and Forecast, By Type
7.3.7. France Orthopedic Implants Market
7.3.7.1. Market Size and Forecast, By Product Type
7.3.7.2. Market Size and Forecast, By Biomaterial
7.3.7.3. Market Size and Forecast, By Type
7.3.8. UK Orthopedic Implants Market
7.3.8.1. Market Size and Forecast, By Product Type
7.3.8.2. Market Size and Forecast, By Biomaterial
7.3.8.3. Market Size and Forecast, By Type
7.3.9. Italy Orthopedic Implants Market
7.3.9.1. Market Size and Forecast, By Product Type
7.3.9.2. Market Size and Forecast, By Biomaterial
7.3.9.3. Market Size and Forecast, By Type
7.3.10. Spain Orthopedic Implants Market
7.3.10.1. Market Size and Forecast, By Product Type
7.3.10.2. Market Size and Forecast, By Biomaterial
7.3.10.3. Market Size and Forecast, By Type
7.3.11. Rest of Europe Orthopedic Implants Market
7.3.11.1. Market Size and Forecast, By Product Type
7.3.11.2. Market Size and Forecast, By Biomaterial
7.3.11.3. Market Size and Forecast, By Type
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product Type
7.4.3. Market Size and Forecast, By Biomaterial
7.4.4. Market Size and Forecast, By Type
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Orthopedic Implants Market
7.4.6.1. Market Size and Forecast, By Product Type
7.4.6.2. Market Size and Forecast, By Biomaterial
7.4.6.3. Market Size and Forecast, By Type
7.4.7. China Orthopedic Implants Market
7.4.7.1. Market Size and Forecast, By Product Type
7.4.7.2. Market Size and Forecast, By Biomaterial
7.4.7.3. Market Size and Forecast, By Type
7.4.8. India Orthopedic Implants Market
7.4.8.1. Market Size and Forecast, By Product Type
7.4.8.2. Market Size and Forecast, By Biomaterial
7.4.8.3. Market Size and Forecast, By Type
7.4.9. Australia Orthopedic Implants Market
7.4.9.1. Market Size and Forecast, By Product Type
7.4.9.2. Market Size and Forecast, By Biomaterial
7.4.9.3. Market Size and Forecast, By Type
7.4.10. South Korea Orthopedic Implants Market
7.4.10.1. Market Size and Forecast, By Product Type
7.4.10.2. Market Size and Forecast, By Biomaterial
7.4.10.3. Market Size and Forecast, By Type
7.4.11. Rest of Asia-Pacific Orthopedic Implants Market
7.4.11.1. Market Size and Forecast, By Product Type
7.4.11.2. Market Size and Forecast, By Biomaterial
7.4.11.3. Market Size and Forecast, By Type
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product Type
7.5.3. Market Size and Forecast, By Biomaterial
7.5.4. Market Size and Forecast, By Type
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Orthopedic Implants Market
7.5.6.1. Market Size and Forecast, By Product Type
7.5.6.2. Market Size and Forecast, By Biomaterial
7.5.6.3. Market Size and Forecast, By Type
7.5.7. Saudi Arabia Orthopedic Implants Market
7.5.7.1. Market Size and Forecast, By Product Type
7.5.7.2. Market Size and Forecast, By Biomaterial
7.5.7.3. Market Size and Forecast, By Type
7.5.8. South Africa Orthopedic Implants Market
7.5.8.1. Market Size and Forecast, By Product Type
7.5.8.2. Market Size and Forecast, By Biomaterial
7.5.8.3. Market Size and Forecast, By Type
7.5.9. Rest of LAMEA Orthopedic Implants Market
7.5.9.1. Market Size and Forecast, By Product Type
7.5.9.2. Market Size and Forecast, By Biomaterial
7.5.9.3. Market Size and Forecast, By Type
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Globus Medical, Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Johnson And Johnson,
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Medtronic Plc
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Zimmer Biomet Holdings Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. NuVasive Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. CONMED Corporation
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Arthrex, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Smith And Nephew Plc
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Stryker Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Colfax Corporation
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
